Amicus Therapeutics (FOLD) Payables (2016 - 2025)
Historic Payables for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $19.1 million.
- Amicus Therapeutics' Payables rose 4170.31% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 4170.31%. This contributed to the annual value of $12.9 million for FY2024, which is 1437.17% down from last year.
- According to the latest figures from Q3 2025, Amicus Therapeutics' Payables is $19.1 million, which was up 4170.31% from $13.9 million recorded in Q2 2025.
- Over the past 5 years, Amicus Therapeutics' Payables peaked at $32.1 million during Q2 2024, and registered a low of $9.2 million during Q1 2024.
- Its 5-year average for Payables is $18.0 million, with a median of $15.4 million in 2022.
- Examining YoY changes over the last 5 years, Amicus Therapeutics' Payables showed a top increase of 13707.29% in 2024 and a maximum decrease of 6310.84% in 2024.
- Quarter analysis of 5 years shows Amicus Therapeutics' Payables stood at $21.5 million in 2021, then dropped by 28.35% to $15.4 million in 2022, then dropped by 1.9% to $15.1 million in 2023, then dropped by 14.37% to $12.9 million in 2024, then skyrocketed by 47.55% to $19.1 million in 2025.
- Its Payables was $19.1 million in Q3 2025, compared to $13.9 million in Q2 2025 and $14.5 million in Q1 2025.